Indigo Diabetes
The company develops an implantable continuous multi-metabolite monitoring (CMM) system using silicon photonics and spectroscopic analysis. The small sensor is designed to measure glucose, ketone, and lactate levels in real-time, transmitting data to a smartphone app for chronic disease management. While initially focused on diabetes, the technology is intended for broader applications in chronic kidney disease, oncology, and cardiovascular health.
Healthtech
Medtech
Medical Devices
Biotechnology
Funding summary
- Total raised
- €38.0M
- Funding rounds
- 1
Investors in Indigo Diabetes
Investors on record for Indigo Diabetes. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Indigo Diabetes?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors